<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33923724</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>16</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>In Vitro Characterization of Neutralizing Hen Antibodies to <i>Coxsackievirus</i> A16.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4146</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22084146</ELocationID><Abstract><AbstractText><i>Coxsackievirus</i> A16 (CA16) is one of the major causative agents of hand, foot, and mouth disease (HFMD). Children aged &lt;5 years are the most affected by CA16 HFMD globally. Although clinical symptoms of CA16 infections are usually mild, severe complications, such as aseptic meningitis or even death, have been recorded. Currently, no vaccine or antiviral therapy for CA16 infection exists. Single-chain variable fragment (scFv) antibodies significantly inhibit viral infection and could be a potential treatment for controlling the infection. In this study, scFv phage display libraries were constructed from splenocytes of a laying hen immunized with CA16-infected lysate. The pComb3X vector containing the scFv genes was introduced into ER2738 <i>Escherichia coli</i> and rescued by helper phages to express scFv molecules. After screening with five cycles of bio-panning, an effective scFv antibody showing favorable binding activity to proteins in CA16-infected lysate on ELISA plates was selected. Importantly, the selected scFv clone showed a neutralizing capability against the CA16 virus and cross-reacted with viral proteins in EV71-infected lysate. Intriguingly, polyclonal IgY antibody not only showed binding specificity against proteins in CA16-infected lysate but also showed significant neutralization activities. Nevertheless, IgY-binding protein did not cross-react with proteins in EV71-infected lysate. These results suggest that the IgY- and scFv-binding protein antibodies provide protection against CA16 viral infection in in vitro assays and may be potential candidates for treating CA16 infection in vulnerable young children.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mwale</LastName><ForeName>Pharaoh Fellow</ForeName><Initials>PF</Initials><Identifier Source="ORCID">0000-0001-9260-8467</Identifier><AffiliationInfo><Affiliation>Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chi-Hsin</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0002-3412-7400</Identifier><AffiliationInfo><Affiliation>Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Peng-Nien</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Linkou Chang Gung Memorial Hospital, Research Center for Emerging Viral Infections, Chang Gung University, Taoyuan 333423, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Sung-Nien</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, Chang Gung University, Taoyuan 333323, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Shin-Ru</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Research Center for Emerging Viral Infections, Chang Gung University, Taoyuan 333423, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hsin-Yuan</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leu</LastName><ForeName>Sy-Jye</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yun-Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiang</LastName><ForeName>Liao-Chun</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Institute of Bioinformatics and Structural Biology, College of Life Sciences, National Tsing Hua University, Hsinchu 300040, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Yan-Chiao</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0002-8561-0582</Identifier><AffiliationInfo><Affiliation>Division of Clinical Toxicology, Department of Emergency Medicine, Taichung Veterans General Hospital, Taichung 407219, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei-Chu</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yi-Yuan</ForeName><Initials>YY</Initials><Identifier Source="ORCID">0000-0003-2534-8436</Identifier><AffiliationInfo><Affiliation>Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Core Laboratory of Antibody Generation and Research, Taipei Medical University, Taipei 110301, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOST108-2622-B-038-003-CC2, MOST 109-2320-B-075A-001, and MOST 109-2320-B-038-053</GrantID><Agency>Ministry of Science and Technology, Taiwan</Agency><Country/></Grant><Grant><GrantID>MOHW108-TDU-B-212-124014 and MOHW 109-TDU-B-212-134014</GrantID><Agency>Ministry of Health and Welfare surcharge of tobacco products</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057127">Single-Chain Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000918" MajorTopicYN="N">Antibody Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057127" MajorTopicYN="N">Single-Chain Antibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus A16 (CA16)</Keyword><Keyword MajorTopicYN="N">Enterovirus 71 (EV71)</Keyword><Keyword MajorTopicYN="N">immunoglobulin yolk (IgY)</Keyword><Keyword MajorTopicYN="N">phage display libraries</Keyword><Keyword MajorTopicYN="N">single-chain variable fragment (scFv)</Keyword></KeywordList><CoiStatement>The authors have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33923724</ArticleId><ArticleId IdType="pmc">PMC8074035</ArticleId><ArticleId IdType="doi">10.3390/ijms22084146</ArticleId><ArticleId IdType="pii">ijms22084146</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yu W., Xu H., Yin C. Molecular epidemiology of human coxsackievirus A16 strains. Biomed. Rep. 2016;4:761&#x2013;764. doi: 10.3892/br.2016.663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2016.663</ArticleId><ArticleId IdType="pmc">PMC4887855</ArticleId><ArticleId IdType="pubmed">27284420</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q., Wang Y., Yao X., Bian L., Wu X., Xu M., Liang Z. Coxsackievirus A16: Epidemiology, diagnosis, and vaccine. Hum. Vaccin. Immunother. 2014;10:360&#x2013;367. doi: 10.4161/hv.27087.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Liu C.-F., Yan L., Li J.-J., Wang L.-J., Qi Y., Cheng R.-B., Xiong X.-Y. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol. J. 2012;9:8. doi: 10.1186/1743-422X-9-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-8</ArticleId><ArticleId IdType="pmc">PMC3268717</ArticleId><ArticleId IdType="pubmed">22230340</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.-Y., Lu F.L., Wu M.-H., Lee C.-Y., Huang L.-M. Fatal coxsackievirus A16 infection. Pediatr. Infect. Dis. J. 2004;23:275&#x2013;276. doi: 10.1097/01.inf.0000115950.63906.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000115950.63906.78</ArticleId><ArticleId IdType="pubmed">15014311</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendig J., Fleming D. Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales. Commun. Dis. Rep. CDR Rev. 1996;6:R81&#x2013;R86.</Citation><ArticleIdList><ArticleId IdType="pubmed">8664928</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia M.-Y., Chiang P.-S., Chung W.-Y., Luo S.-T., Lee M.-S. Epidemiology of enterovirus 71 infections in Taiwan. Pediatr. Neonatol. 2014;55:243&#x2013;249. doi: 10.1016/j.pedneo.2013.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2013.07.007</ArticleId><ArticleId IdType="pubmed">24120535</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K., Han X., Wang G., Hu W., Zhang W., Yu X.-F. Circulating coxsackievirus A16 identified as recombinant type A human enterovirus, China. Emerg. Infect. Dis. 2011;17:1537. doi: 10.3201/eid1708.101719.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1708.101719</ArticleId><ArticleId IdType="pmc">PMC3381541</ArticleId><ArticleId IdType="pubmed">21801645</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhu Z., Yang W., Ren J., Tan X., Wang Y., Mao N., Xu S., Zhu S., Cui A. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol. J. 2010;7:94. doi: 10.1186/1743-422X-7-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q.-y., Wang Y., Bian L., Xu M., Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert Rev. Vaccines. 2016;15:599&#x2013;606. doi: 10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S., Wu F., Ye X., Fu T., Tao J., Luo W., Wang Y., Jia J., Lou L. Safety comparison of two enterovirus 71 (EV71) inactivated vaccines in Yiwu, China. J. Trop. Pediatr. 2019;65:547&#x2013;551. doi: 10.1093/tropej/fmz004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmz004</ArticleId><ArticleId IdType="pubmed">31079146</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y., Chu J. Sinovac EV71 vaccine: The silver bullet for hand, foot and mouth disease&#x2014;Or not. J. Public Health Emerg. 2017;1 doi: 10.21037/jphe.2016.12.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jphe.2016.12.14</ArticleId></ArticleIdList></Reference><Reference><Citation>Marston H.D., Paules C.I., Fauci A.S. Monoclonal antibodies for emerging infectious diseases&#x2014;Borrowing from history. N. Engl. J. Med. 2018;378:1469&#x2013;1472. doi: 10.1056/NEJMp1802256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1802256</ArticleId><ArticleId IdType="pubmed">29513615</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolph H., Schroten H., Tenenbaum T. Enterovirus Infections of the Central Nervous System in Children: An Update. Pediatr. Infect. Dis. J. 2016;35:567&#x2013;569. doi: 10.1097/INF.0000000000001090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001090</ArticleId><ArticleId IdType="pubmed">26862675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda M., Niwa S., Sekizuka T., Tsukagoshi H., Yokoyama M., Ryo A., Sato H., Kiyota N., Noda M., Kozawa K. Molecular evolution of the VP1, VP2, and VP3 genes in human rhinovirus species C. Sci. Rep. 2015;5:8185. doi: 10.1038/srep08185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep08185</ArticleId><ArticleId IdType="pmc">PMC4313092</ArticleId><ArticleId IdType="pubmed">25640899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis J.K., Bothner B., Smith T.J., Siuzdak G. Antiviral agent blocks breathing of the common cold virus. Proc. Nat. Acad. Sci. USA. 1998;95:6774&#x2013;6778. doi: 10.1073/pnas.95.12.6774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.12.6774</ArticleId><ArticleId IdType="pmc">PMC22631</ArticleId><ArticleId IdType="pubmed">9618488</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss M., Filman D.J., Belnap D.M., Cheng N., Noel R.T., Hogle J.M. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry. J. Virol. 2015;89:4143&#x2013;4157. doi: 10.1128/JVI.03101-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03101-14</ArticleId><ArticleId IdType="pmc">PMC4442392</ArticleId><ArticleId IdType="pubmed">25631086</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird R.E., Hardman K.D., Jacobson J.W., Johnson S., Kaufman B.M., Lee S.-M., Lee T., Pope S.H., Riordan G.S., Whitlow M. Single-chain antigen-binding proteins. Science. 1988;242:423&#x2013;426. doi: 10.1126/science.3140379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3140379</ArticleId><ArticleId IdType="pubmed">3140379</ArticleId></ArticleIdList></Reference><Reference><Citation>Huston J.S., Levinson D., Mudgett-Hunter M., Tai M.-S., Novotn&#xfd; J., Margolies M.N., Ridge R.J., Bruccoleri R.E., Haber E., Crea R. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Nat. Acad. Sci. USA. 1988;85:5879&#x2013;5883. doi: 10.1073/pnas.85.16.5879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.16.5879</ArticleId><ArticleId IdType="pmc">PMC281868</ArticleId><ArticleId IdType="pubmed">3045807</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Zhang R., Chen X. Application of a single-chain fragment variable (scFv) antibody for the confirmatory diagnosis of hydatid disease in non-endemic areas. Electron. J. Biotechnol. 2017;29:57&#x2013;62. doi: 10.1016/j.ejbt.2017.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejbt.2017.07.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Krag D.N., Shukla G.S., Shen G.-P., Pero S., Ashikaga T., Fuller S., Weaver D.L., Burdette-Radoux S., Thomas C. Selection of tumor-binding ligands in cancer patients with phage display libraries. Cancer Res. 2006;66:7724&#x2013;7733. doi: 10.1158/0008-5472.CAN-05-4441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-05-4441</ArticleId><ArticleId IdType="pubmed">16885375</ArticleId></ArticleIdList></Reference><Reference><Citation>Unkauf T., Miethe S., F&#xfc;hner V., Schirrmann T., Frenzel A., Hust M. Protein Targeting Compounds. Springer; New York, NY, USA: 2016. Generation of recombinant antibodies against toxins and viruses by phage display for diagnostics and therapy; pp. 55&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121732</ArticleId><ArticleId IdType="pubmed">27236552</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti D., Voss J., Gamblin S.J., Codoni G., Macagno A., Jarrossay D., Vachieri S.G., Pinna D., Minola A., Vanzetta F. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science. 2011;333:850&#x2013;856. doi: 10.1126/science.1205669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1205669</ArticleId><ArticleId IdType="pubmed">21798894</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota T., Milenic D.E., Whitlow M., Schlom J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 1992;52:3402&#x2013;3408.</Citation><ArticleIdList><ArticleId IdType="pubmed">1596900</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyo H.-M., Kim I.-J., Kim S.-H., Kim H.-S., Cho S.-D., Cho I.-S., Hyun B.-H. Escherichia coli expressing single-chain Fv on the cell surface as a potential prophylactic of porcine epidemic diarrhea virus. Vaccine. 2009;27:2030&#x2013;2036. doi: 10.1016/j.vaccine.2009.01.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.01.130</ArticleId><ArticleId IdType="pubmed">19428826</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmsen M., Fijten H., Engel B., Dekker A., Ebl&#xe9; P. Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs. Vaccine. 2009;27:904&#x2013;1911. doi: 10.1016/j.vaccine.2009.01.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.01.110</ArticleId><ArticleId IdType="pubmed">19368770</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird C.R., Thorpe R. The Protein Protocols Handbook. Springer; New York, NY, USA: 2009. Purification of immunoglobulin Y (IgY) from chicken eggs; pp. 1779&#x2013;1781.</Citation></Reference><Reference><Citation>Deng X.K., Nesbit L.A., Morrow K.J. Recombinant Single-Chain Variable Fragment Antibodies Directed against Clostridium difficile Toxin B Produced by Use of an Optimized Phage Display System. Clin. Diagn. Lab. Immunol. 2003;10:587&#x2013;595. doi: 10.1128/CDLI.10.4.587-595.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CDLI.10.4.587-595.2003</ArticleId><ArticleId IdType="pmc">PMC164272</ArticleId><ArticleId IdType="pubmed">12853390</ArticleId></ArticleIdList></Reference><Reference><Citation>Fehrsen J., Wemmer S., van Wyngaardt W. Construction of Chicken Antibody Libraries. In: Hust M., Lim T.S., editors. Phage Display: Methods and Protocols. Springer; New York, NY, USA: 2018. pp. 189&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">29116506</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q., Ding J., Cao J., Huang Q., Hong C., Yang B. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: Outbreaks of coxsackieviruses A10. J. Med. Virol. 2015;87:954&#x2013;960. doi: 10.1002/jmv.24151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24151</ArticleId><ArticleId IdType="pubmed">25754274</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilvebrant J., Sidhu S.S. Phage Display. Springer; New York, NY, USA: 2018. Construction of synthetic antibody phage-display libraries; pp. 45&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">29116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva M.C., Schaefer R., Gava D., Souza C.K., da Silva Vaz I., Jr., Bastos A.P., Venancio E.J. Production and application of anti-nucleoprotein IgY antibodies for influenza A virus detection in swine. J. Immunol. Methods. 2018;461:100&#x2013;105. doi: 10.1016/j.jim.2018.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2018.06.023</ArticleId><ArticleId IdType="pubmed">30158073</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.-H., Leu S.-J., Lee Y.-C., Liu C.-I., Lin L.-T., Mwale P.F., Chiang J.-R., Tsai B.-Y., Chen C.-C., Hung C.-S. Characterization of chicken-derived single chain antibody fragments against venom of Naja naja atra. Toxins. 2018;10:383. doi: 10.3390/toxins10100383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins10100383</ArticleId><ArticleId IdType="pmc">PMC6215181</ArticleId><ArticleId IdType="pubmed">30248928</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y., Liu Q., Huang X., Li D., Ku Z., Zhang Y., Huang Z. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine. 2013;31:2215&#x2013;2221. doi: 10.1016/j.vaccine.2013.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.03.007</ArticleId><ArticleId IdType="pubmed">23499596</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Liu Q., Cai Y., Leng Q., Huang Z. Construction and characterization of an infectious clone of coxsackievirus A16. Virol. J. 2011;8:534. doi: 10.1186/1743-422X-8-534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-534</ArticleId><ArticleId IdType="pmc">PMC3283524</ArticleId><ArticleId IdType="pubmed">22165961</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T.-W., Cheng S.-F., Tseng Y.-T., Yang Y.-C., Liu W.-C., Wang S.-C., Chou M.-J., Lin Y.-J., Wang Y., Hsiao P.-W. Development of single-chain variable fragments (scFv) against influenza virus targeting hemagglutinin subunit 2 (HA2) Arch. Virol. 2016;161:19&#x2013;31. doi: 10.1007/s00705-015-2625-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-015-2625-6</ArticleId><ArticleId IdType="pubmed">26446888</ArticleId></ArticleIdList></Reference><Reference><Citation>Du R., Mao Q., Hu Y., Lang S., Sun S., Li K., Gao F., Bian L., Yang C., Cui B., et al. A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge. Hum. Vaccines Immunother. 2019;15:2343&#x2013;2350. doi: 10.1080/21645515.2019.1565266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2019.1565266</ArticleId><ArticleId IdType="pmc">PMC6816366</ArticleId><ArticleId IdType="pubmed">30735461</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Dai W., Zhang C., Zhou Y., Xiong P., Wang S., Ye X., Liu Q., Zhou D., Huang Z. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Emerg. Microbes Infect. 2018;7:1&#x2013;12. doi: 10.1038/s41426-018-0094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0094-1</ArticleId><ArticleId IdType="pmc">PMC5959873</ArticleId><ArticleId IdType="pubmed">29777102</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Wang X., Li X., Ma Z., Feng R. Construction, expression, and characterization of a single-chain variable fragment (ScFv) antibody targeting to the encephalomyocarditis virus. J. Med. Virol. 2018;90:1184&#x2013;1191. doi: 10.1002/jmv.25065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25065</ArticleId><ArticleId IdType="pubmed">29476627</ArticleId></ArticleIdList></Reference><Reference><Citation>Mwale P.F., Lee C.-H., Leu S.-J., Lee Y.-C., Wu H.-H., Lin L.-T., Lin T.E., Huang Y.-J., Yang Y.-Y. Antigenic epitopes on the outer membrane protein A of Escherichia coli identified with single-chain variable fragment (scFv) antibodies. Appl. Microbiol. Biotechnol. 2019;103:5285&#x2013;5299. doi: 10.1007/s00253-019-09761-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-019-09761-8</ArticleId><ArticleId IdType="pubmed">31028439</ArticleId></ArticleIdList></Reference><Reference><Citation>Leu S.-J., Lee Y.-C., Shih N.-Y., Huang I.-J., Liu K.-J., Lu H.-F., Huang S.-Y., Yang Y.-Y. Generation and characterization of anti-&#x3b1;-enolase single-chain antibodies in chicken. Vet. Immunol. Immunopathol. 2010;137:251&#x2013;260. doi: 10.1016/j.vetimm.2010.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2010.06.001</ArticleId><ArticleId IdType="pmc">PMC7112641</ArticleId><ArticleId IdType="pubmed">20655599</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpe K. Overview of bacterial expression systems for heterologous protein production: From molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 2006;72:211. doi: 10.1007/s00253-006-0465-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-006-0465-8</ArticleId><ArticleId IdType="pubmed">16791589</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikunova N., Morozova V. Phage display on the base of filamentous bacteriophages: Application for recombinant antibodies selection. Acta Nat. 2009;1:20&#x2013;28. doi: 10.32607/20758251-2009-1-3-20-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.32607/20758251-2009-1-3-20-28</ArticleId><ArticleId IdType="pmc">PMC3347532</ArticleId><ArticleId IdType="pubmed">22649612</ArticleId></ArticleIdList></Reference><Reference><Citation>Backman L., Persson K. The No-Nonsens SDS-PAGE. Methods Mol. Biol. 2018;1721:89&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">29423849</ArticleId></ArticleIdList></Reference><Reference><Citation>Engvall E., Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 1971;8:871&#x2013;874. doi: 10.1016/0019-2791(71)90454-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0019-2791(71)90454-X</ArticleId><ArticleId IdType="pubmed">5135623</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>